Page last updated: 2024-11-07

methylprednisolone acetate and Retinal Degeneration

methylprednisolone acetate has been researched along with Retinal Degeneration in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piccolino, FC1
Pandolfo, A1
Polizzi, A1
Eandi, CM1
Ventre, L1

Other Studies

1 other study available for methylprednisolone acetate and Retinal Degeneration

ArticleYear
Retinal toxicity from accidental intraocular injection of depo-medrol.
    Retina (Philadelphia, Pa.), 2002, Volume: 22, Issue:1

    Topics: Adolescent; Anti-Inflammatory Agents; Eye Injuries, Penetrating; Female; Fluorescein Angiography; Hu

2002